Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Myocyte-derived Myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers
Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, Douglas P. Millay
Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, Douglas P. Millay
View: Text | PDF
Research Article Muscle biology Stem cells

Myocyte-derived Myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers

  • Text
  • PDF
Abstract

Muscle progenitor cell fusion is required for the formation and regeneration of multinucleated skeletal muscle fibers. Chronic muscle regeneration in Duchenne muscular dystrophy (DMD) is characterized by ongoing fusion of satellite cell (SC) progeny, but the effects of fusion on disease and the mechanisms by which fusion is accomplished in this setting are not fully understood. Using the mdx mouse model of DMD, we deleted the fusogenic protein Myomaker in SCs or myofibers. Following deletion in SCs, mice displayed a complete lack of myocyte fusion, resulting in severe muscle loss, enhanced fibrosis, and significant functional decline. Reduction of Myomaker in mature myofibers in mdx mice, however, led to minimal alterations in fusion dynamics. Unexpectedly, myofiber-specific deletion of Myomaker resulted in improvement of disease phenotype, with enhanced function and decreased muscle damage. Our data indicate that Myomaker has divergent effects on dystrophic disease severity depending upon its compartment of expression. These findings show that myocyte fusion is absolutely required for effective regeneration in DMD, but persistent Myomaker expression in myofibers due to ongoing fusion may have unintended deleterious consequences for muscle integrity. Thus, sustained activation of a component of the myogenic program in dystrophic myofibers exacerbates disease.

Authors

Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, Douglas P. Millay

×

Figure 6

Muscle function is improved in mdx mice following myofiber-specific deletion of Myomaker.

Options: View larger image (or click on image) Download as PowerPoint
Muscle function is improved in mdx mice following myofiber-specific dele...
(A) Specific force of tibialis anterior (TA) muscle upon in situ muscle functional measurement (n = 7). (B) Upon repeated nerve stimulation to assay fatigability, mdx MymkfiberKO mice showed greater resistance to muscle fatigue (n = 7). (C) Immunofluorescence staining for myofiber type–specific myosin heavy chains revealed no change in myofiber type distribution of mdx MymkfiberKO TA muscle (n = 4–5). Statistical analyses and data presentation: (A and B) unpaired t test; *P < 0.05, **P < 0.01. Data are represented as mean ± SD. Scale bar: 50 μm (C).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts